RankAlpha logo
Back to Rankings

RANI

Rani TherapeuticsC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
RT-114 Phase 1 progress, possible Chugai milestone conversion and improved strategic leadership could validate RaniPill and support substantial upside from the depressed share price.
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
CFO transition and limited external coverage increase execution and information risk.
Momentum
85
Value
41
Sentiment
54
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.75 · Bull $1.35 · Bear $0.25Analysis 2026-07-14; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-14 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-09

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions

Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $7.20
Why
Momentum85 · Δ7d -
Value41 · Δ7d 0.0
Sentiment54 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.

Confirming evidence

  • Sentiment remains the lead driver in the composite.

Contradictions & invalidation

  • CFO transition and limited external coverage increase execution and information risk.
  • Cash runway depends partly on expected milestone timing and disciplined operating burn; future dilution remains possible.
  • Rani remains pre-commercial and clinically binary.

Catalyst clock

2026-12-31

Chugai collaboration milestone conversion

Lead driver: Sentiment · See AI snapshot
Momentum
85
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
54
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade C. Momentum 84.6 / Value 41.2 / Sentiment 54.0

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-14. Scenario method

B+
Bull case
25%
Probability
Target price
$1.35
Analysis reference price unavailable
Analysis 2026-07-14 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$0.75
Analysis reference price unavailable
Analysis 2026-07-14 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$0.25
Analysis reference price unavailable
Analysis 2026-07-14 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$108.53M
Beta
0.44
Shares Out
112.39M
P/E (TTM) · Derived
-2.2
P/S (TTM)
137.72
P/FCF (TTM) · Derived
-5.04
Rev YoY
+893.0%
EPS YoY
-78.4%
Gross Margin
+84.2%
Op Margin
-3727.8%
Net Debt
-$45.59M
Current Ratio
5.31
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data